Novo Nordisk's Ozempic will become the first and only GLP-1 drug to be shown to reduce progression of kidney disease in ...
Identifying the early signs of kidney stone disease is crucial for preventing complications and managing symptoms.
A university has refunded a PhD student's tuition fees due to the distress caused by her being unable to pay for her studies.
Explore the disproportionate burden of chronic kidney disease in the Black community and the need for empowerment and ...
New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of chronic kidney disease.
But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...
“My feet would be really swollen after uni. I used to elevate them but they weren’t getting better so my parents persuaded me ...
significantly reduces the risk of progression in chronic kidney disease and cardiovascular mortality in patients with type 2 diabetes. The label expansion could enhance Novo Nordisk’s market ...
Jefferies upgrades Vertex Pharmaceuticals to Buy, highlighting a promising pipeline and $5 billion-$7 billion growth ...